Your Article Summary
See Latest ArticlesSurvival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine and dacarbazine chemotherapy
Journal of Clinical Endocrinology and Metabolism, 06/09/09
Nomura K et al. - In a study to analyze survival curves and survival times of pts with malignant pheochromocytoma and determine the efficacy of chemotherapy on prolongation of life, this study revealed a long survival time. Vincristine and dacarbazine (CVD) chemotherapy was not shown to extend survival, especially for women and pts with adrenal gland-derived primary tumors.
Methods- This was an inception cohort and Kaplan-Meier survival analysis.
- 32 pts with metastasized malignant pheochromocytoma were analyzed for survival.
- 25 pts had undergone excision of their primary tumors.
- Survival curves were compared among 16 pts in the group treated with combined chemotherapy using CVD and 9 pts not treated with chemotherapy.
- The survival curve of the 32 pts declined continuously and linearly to at least 20 yrs after diagnosis of pheochromocytoma.
- The 50% survival rate was estimated to be 14.7 yrs.
- In the 25 pts whose primary tumor was excised, pts who already had metastases at the time of pheochromocytoma diagnosis had better survival than those whose metastases were found later.
- Survival rate after diagnosis of metastasis was worse in the CVD group than in controls.
- When the effects of CVD were examined after stratifying several factors, female gender and adrenal origin of tumor were found to be negative prognostic factors for CVD chemotherapy.
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters
Experimental and Clinical Endocrinology & Diabetes, 12/19/09
Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
Experimental and Clinical Endocrinology & Diabetes, 12/19/09
Thyroid follicular neoplasm: Analysis by fine needle aspiration cytology, frozen section, and histopathology
Diagnostic Cytopathology, 12/18/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09